We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
Text descriptions of graphs on the Gender Equity 2023–24 Report Card.
Career Stage – Years Post-PhD
Three pie charts showing the number of grants (funded rate) for lead Chief Investigators by their career stage in 2023–24.
0 to less than 10 years post-PhD:
- 167 women (13.4%)
- 127 men (11.7%).
10 to less than 20 years post-PhD:
- 142 women (13.2%)
- 119 men (12.1%)
- 3 other (12.5%).
20 or more years post-PhD:
- 87 women (17.4%)
- 133 men (15.2%)
- 3 other (30%).
Note: Funded CIAs with a PhD not complete or awarded are not shown.
Funded rate
Vertical bar chart representing the funded rate (percentage) for women, men and other lead Chief Investigators in the NHMRC grant program for 2023–24.
- 14.8% women
- 13.5% men
- 7.6% other.
Note: The funded rate is the percentage of applications that receive funding.
Schemes
A vertical bar chart representing the funded rate for women and men lead Chief Investigators and the proportion of grants awarded to women by scheme for 2023–24.
| Scheme | Proportion of grants - Women (CIA) | Funded rate - Women (CIA) | Funded rate - Men (CIA) |
|---|---|---|---|
| 2023 Centres of Research Excellence | 64% | 23.1% | 12.5% |
| 2023 Clinical Trials and Cohort Studies Grants | 48% | 11.8% | 10.5% |
| 2023 Development Grants | 14% | 8.0% | 14.1% |
| 2023 Ideas Grants | 43% | 11.2% | 11.1% |
| International Collaborations* | 53% | 31.0% | 22.9% |
| 2023 Investigator Grants | 52% | 14.5% | 14.1% |
| 2024 Investigator Grants | 55% | 14.3% | 13.2% |
| 2022/2023 Partnership Projects^ | 65% | 32.3% | 33.3% |
| 2023 Postgraduate Scholarships | 55% | 40.7% | 46.6% |
| 2023 Synergy Grants | 60% | 24.0% | 16.0% |
| Targeted Calls for Research* | 78% | 17.1% | 10.0% |
*Includes multiple grant opportunity rounds.
^Includes 2022 PRC3 and 2023 PRC1 and PRC2.
All chief investigators
Horizontal bar chart representing the funded rate for all women, men and other Chief Investigators in the NHMRC grant program in 2023–24.
The funded rate was:
- 15.7% for women
- 14.3% for men
- 11.6% for other.
Structural priority funding
Vertical bar chart representing the baseline (before structural priority funding) and final funded rates for women and men lead Chief Investigators in relevant schemes in 2023–24.
- For Ideas Grants, the baseline funded rate was 9.1% for women and 10.7% for men. The final funded rate was 11.2% for women and 11.1% for men.
- For 2023 Investigator Grants Emerging Leadership category, the baseline funded rate was 10.2% for women and 12.7% for men. The final funded rate was 13.1% for women and 12.9% for men.
- For 2024 Investigator Grants Emerging Leadership category, the baseline funded rate was 9.9% for women and 13.1% for men. The final funded rate was 13.1% for women and 13.4% for men.
- For Clinical Trials and Cohort Studies, the baseline funded rate was 7.8% for women and 10.5% for men. The final funded rate was 11.8% for women and 10.5% for men.
Note: Data are only show for schemes in which SPF for gender equity was applied. The 'Final' funded rate incorporates all structural priorities, not only gender. 'Baseline' is the funded rate prior to SPF. 'Other' category is not shown.
Impact of special measures on Investigator Grant Leadership category
Horizontal bar chart representing the number of women, men and other by leadership category for 2023 and 2024.
2023:
- Leadership 1 (L1): 22 women, 7 men.
- Leadership 2 (L2): 17 women, 22 men and 1 other
- Leadership 3 (L3): 12 women, 20 men and 2 other.
2024:
- Leadership 1 (L1): 18 women, 12 men and 2 other
- Leadership 2 (L2): 20 women, 14 men
- Leadership 3 (L3): 15 women, 24 men.